Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Does Low-Molecular-Weight Heparin Influence the Antimyeloma Effects of Thalidomide? A Retrospective Analysis of Data from the GIMEMA, Nordic and Turkish Myeloma Study Groups

Acta Haematol (2015) 133 (4): 372–380.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Low-dose low-molecular-weight heparin prophylaxis against obstetrical complications in pregnancies with metabolic and immunological disorder-associated placental inflammation

Mehmet Sinan Beksac
Atakan Tanacan
Gonca Ozten
Ayse Nur Cakar

The Journal of Maternal-Fetal & Neonatal Medicine (2022) 35 (8): 1546.